John Fletcher Named Strategic Advisor to Micro Medical Solutions

As MMS prepares for approval of their pivotal clinical trial of the company's flagship MicroStent device, one of healthcare's top growth experts will help shape the company's future WILMINGTON, Mass., May 14, 2019 -- (Healthcare Sales & Marketing Networ... Devices, Interventional, Personnel Micro Medical Solutions, MicroStent, peripheral artery disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news